Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

Oncology

Multiple Myeloma

Advertisement

Strategies for Improving Outcomes in Multiple Myeloma

Multiple Myeloma

Strategies for Improving Outcomes in Multiple Myeloma

patient care perspectives
By Rafat Abonour, MD

The Assessment of Measurable Residual Disease in Multiple Myeloma

Multiple Myeloma

The Assessment of Measurable Residual Disease in Multiple Myeloma

clinical topic updates
By Rafat Abonour, MD

$Expert Roundtables Podcast: Defining the Needs of Today’s Patients With Relapsed/Refractory Multiple Myeloma$

Multiple Myeloma

Expert Roundtables Podcast: Defining the Needs of Today’s Patients With Relapsed/Refractory Multiple Myeloma

expert roundtables
By David E. Avigan, MD; Irene M. Ghobrial, MD; Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO

Toxicity-Sparing Strategies and Supportive Care in Relapsed Multiple Myeloma

Multiple Myeloma

Toxicity-Sparing Strategies and Supportive Care in Relapsed Multiple Myeloma

expert roundtables
By David E. Avigan, MD; Irene M. Ghobrial, MD; Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO

$Maintaining Hope While Facing Multiply Refractory Multiple Myeloma$

Multiple Myeloma

Maintaining Hope While Facing Multiply Refractory Multiple Myeloma

patient care perspectives
By David E. Avigan, MD

Load More

Experts in Multiple Myeloma

+8

Meet the Experts

Advertisement

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?